Appropriate ICD Interventions for Ventricular Arrhythmias Are Predicted by Higher Syntax Scores I and II in Patients with Ischemic Heart Disease
- PMID: 33922775
- PMCID: PMC8123075
- DOI: 10.3390/jcm10091843
Appropriate ICD Interventions for Ventricular Arrhythmias Are Predicted by Higher Syntax Scores I and II in Patients with Ischemic Heart Disease
Abstract
Aims: The occurrence of ventricular arrhythmias (VAs) in ischemic heart disease (IHD) patients is related to the presence and extent of fibrotic/scar tissue. As coronary atherosclerosis is the underlying cause of myocardial ischemia and fibrosis, in IHD patients implanted with an implantable cardioverter defibrillator (ICD) we investigated the relation between the VA burden and the complexity of coronary atherosclerotic lesions.
Methods and results: In IHD patients who underwent coronary angiography and ICD implant, the Syntax scores I and II (SSI-II), as index of the severity of the coronary atherosclerotic disease, and the occurrence of VA were assessed. Overall 144 patients were included (123 males). Of these 22 patients (15%) experienced at least one episode of VA (cycle length 298 ± 19 msec) that required ICD intervention. The number of episodes per patient and per year was 4 ± 6 and 2.8 ± 4, respectively. Patients that experienced a VA compared to those free from arrhythmic events did not have distinct baseline clinical characteristics except for a higher SS I and SS II (21 (IQR 13-38) vs. 16 (IQR 10-23); p = 0.037; and 50 (IQR 39-62) vs. 42 (IQR 34-50); p = 0.012). In the binary logistic regression analyses the SS I and II were the only independent predictors of VA occurrence. A higher SS II was also associated with an earlier time to first event (p = 0.005).
Conclusion: Higher SS I-II scores reflect a more severe coronary atherosclerosis and are associated with a greater VA burden. Further studies are needed to better clarify the ability of SSI-II to stratify the risk of IHD patients to develop life-threatening VA.
Keywords: coronary artery disease; heart failure; implantable cardiac defibrillator; ventricular arrhythmias.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.JACC Cardiovasc Interv. 2017 May 8;10(9):879-888. doi: 10.1016/j.jcin.2017.02.008. JACC Cardiovasc Interv. 2017. PMID: 28473110
-
Chronic total occlusion of an infarct-related artery: a new predictor of ventricular arrhythmias in primary prevention implantable cardioverter defibrillator patients.Europace. 2017 Feb 1;19(2):267-274. doi: 10.1093/europace/euw009. Europace. 2017. PMID: 28175266
-
Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.Kardiol Pol. 2012;70(12):1264-75. Kardiol Pol. 2012. PMID: 23264245
-
Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.J Am Coll Cardiol. 2018 Oct 2;72(14):1653-1676. doi: 10.1016/j.jacc.2017.10.052. Epub 2017 Oct 30. J Am Coll Cardiol. 2018. PMID: 29097297
-
Systematic review for the 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.Heart Rhythm. 2018 Oct;15(10):e253-e274. doi: 10.1016/j.hrthm.2017.10.037. Epub 2017 Nov 4. Heart Rhythm. 2018. PMID: 29097318
Cited by
-
Evaluation of Inflammatory Markers in Predicting Coronary Complexity: Insights from the SYNTAX II Score in NSTEMI Patients.J Clin Med. 2024 Oct 6;13(19):5940. doi: 10.3390/jcm13195940. J Clin Med. 2024. PMID: 39408000 Free PMC article.
-
Incidence and risk factors for first and recurrent ICD shock therapy in patients with an implantable cardioverter defibrillator.J Interv Card Electrophysiol. 2025 Jan;68(1):125-139. doi: 10.1007/s10840-024-01873-0. Epub 2024 Aug 21. J Interv Card Electrophysiol. 2025. PMID: 39168942 Free PMC article.
References
-
- Priori S.G., Blomström-Lundqvist C., Mazzanti A., Blom N., Borggrefe M., Camm J., Elliott P.M., Fitzsimons D., Hatala R., Hindricks G., et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Associ-ation for European Paediatric and Congenital Cardiology (AEPC) Europace. 2015;17:1601–1687. - PubMed
-
- Kremers M.S., Hammill S.C., Berul C.I., Koutras C., Curtis J.S., Wang Y., Beachy J., Meisnere L.B., Conyers D.M., Reynolds M.R., et al. The National ICD Registry Report: Version 2.1 including leads and pediatrics for years 2010 and 2011. Hear. Rhythm. 2013;10:e59–e65. doi: 10.1016/j.hrthm.2013.01.035. - DOI - PubMed
-
- Wit A.L., Wellens H.J., Josephson M.E. Electrophysiological Foundations of Cardiac Arhhythmias. Cardiotext Publishing; Minneapolis, MN, USA: 2017. pp. 197–242. May 2017. Chapter 9.
-
- Scott P.A., Morgan J.M., Carroll N., Murday D.C., Roberts P.R., Peebles C.R., Harden S.P., Curzen N.P. The Extent of Left Ventricular Scar Quantified by Late Gadolinium Enhancement MRI Is Associated with Spontaneous Ventricular Arrhythmias in Patients with Coronary Artery Disease and Implantable Cardioverter-Defibrillators. Circ. Arrhythmia Electrophysiol. 2011;4:324–330. doi: 10.1161/CIRCEP.110.959544. - DOI - PubMed
-
- Wu E., Ortiz J.T., Tejedor P., Lee D.C., Bucciarelli-Ducci C., Kansal P., Carr J.C., Holly T.A., Lloyd-Jones D., Klocke F.J., et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: Prospective cohort study. Heart. 2008;94:730–736. doi: 10.1136/hrt.2007.122622. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials